Search Tag: hypertrophic cardiomyopathy

2024 22 May

  Despite advances in reducing mortality and hospitalisation rates, individuals living with hypertrophic cardiomyopathy (HCM) often experience compromised quality of life due to symptoms like exertional dyspnoea and reduced exercise capacity. A significant contributor to these challenges in HCM patients is left ventricular outflow tract (LVOT) obstruction,...Read more

2022 21 Jun

New recommendations published in the European Journal of Preventive Cardiology highlight the use of gene testing to prevent sudden cardiac death in athletes and enable safe exercise.  The new guidelines focus on the athletes who should be tested and when they should be tested. It is also recommended that the athletes who undergo genetic testing...Read more

2019 12 Jun

The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that family screening for hypertrophic cardiomyopathy (HCM) should start at the age of 12 years. Screening earlier than this is only recommended in cases with an early growth spurt, family history of sudden cardiac death and prior to competitive sports...Read more

2019 29 May

When we talk about hypertrophic cardiomyopathy (HCM), sudden cardiac death (SCD) is one of the most devastating complications associated with this disease. It is also one of the most common causes of SCD in the young. However, the management of HCM has been made possible through the use of implantable cardioverter/defibrillators (ICDs), which were...Read more

2015 09 Jan

According to a new study, researchers have found that in addition to gene mutations, environmental stress also plays a key role in the development of the heart disease, hypertrophic cardiomyopathy. This is a heritable and potentially fatal heart disease that causes irregular heartbeats, heart valve problems, heart failure and in some rare cases, even...Read more